| Literature DB >> 30774261 |
Neelam Rawat1, Deepak Kumar1, A K Upadhyay1.
Abstract
BACKGROUND AND AIM: Campylobacteriosis finds its place among the four important global foodborne illnesses. The disease, though self-limiting, needs antibacterial therapy in extraintestinal complications. Therefore, the present study was designed to estimate the prevalence of thermophilic Campylobacters in poultry, animals, and humans of the Kumaon region of Uttarakhand.Entities:
Keywords: antibiotic susceptibility; thermophilic Campylobacters; virulence
Year: 2018 PMID: 30774261 PMCID: PMC6362333 DOI: 10.14202/vetworld.2018.1698-1705
Source DB: PubMed Journal: Vet World ISSN: 0972-8988
Figure-1Agarose gel showing polymerase chain reaction product specific for genus Campylobacter spp. (16SrRNA), Lane M: 100bp ladder, Lanes 1-7: Campylobacter isolates (816 bp).
Figure-2Multiplex polymerase chain reaction for Campylobacter genus and species identification. Lane M: 100 bp ladder, Lanes 1, 2, 3, 5, 6, 7: Campylobacter coli, Lane 4: Campylobacter jejuni.
Distribution of Campylobacter isolates across various samples.
| Sample source | Number of samples collected | Number of positive samples (%) | ||
|---|---|---|---|---|
| Poultry droppings | 203 | 12 (5.91) | 3 (25) | 9 (75) |
| Poultry ceca | 116 | 18 (15.52) | 2 (11.11) | 16 (88.89) |
| Cattle feces | 61 | 3 (4.92) | 1 (33.33) | 2 (66.67) |
| Sheep and goat feces | 36 | 0 (0) | 0 (0) | 0 (0) |
| Pig feces | 71 | 2 (2.82) | 0 (0) | 2 (100) |
| Laboratory animals’ feces | 34 | 0 (0) | 0 (0) | 0 (0) |
| Human stools | 88 | 3 (3.41) | 3 (100) | 0 (0) |
| Total | 609 | 38 (6.24) | 9 (23.68) | 29 (76.32) |
Figure-3Gel electrophoresis of polymerase chain reaction (PCR) product flaA (450 bp), Lane M: 100 bp ladder, Lane 1: Escherichia coli, Lanes 2-20: flaA PCR product.
Prevalence of virulent genes in Campylobacter isolates recovered from various sources.
| Source | Number of isolates | Virulence genes detected in | |||
|---|---|---|---|---|---|
| Poultry droppings | 12 | 12 (100) | 12 (100) | 2 (16.67) | 5 (41.67) |
| Poultry ceca | 18 | 18 (100) | 18 (100) | 3 (16.67) | 4 (22.22) |
| Cattle feces | 3 | 3 (100) | 2 (66.67) | 1 (33.33) | 2 (66.67) |
| Sheep and goat feces | 0 | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Pig feces | 2 | 2 (100) | 2 (100) | 0 (0) | 0 (0) |
| Laboratory animals’ feces | 0 | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Human stools | 3 | 3 (100) | 3 (100) | 1 (33.33) | 3 (100) |
| Total | 38 | 38 (100) | 37 (97.37) | 7 (18.42) | 14 (36.84) |
Distribution of virulent genes among the Campylobacter isolates.
| Source | Total number of isolates | Virulent genes detected in | ||||
|---|---|---|---|---|---|---|
| Poultry droppings | 3 | 3 | 3 | 2 | 2 | |
| 9 | 9 | 9 | 0 | 3 | ||
| Poultry ceca | 2 | 2 | 2 | 1 | 1 | |
| 16 | 16 | 16 | 2 | 3 | ||
| Cattle feces | 1 | 1 | 1 | 1 | 1 | |
| 2 | 2 | 1 | 0 | 1 | ||
| Sheep and goat feces | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| Pig feces | 0 | 0 | 0 | 0 | 0 | |
| 2 | 2 | 2 | 0 | 0 | ||
| Laboratory animals’ feces | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | ||
| Human stools | 3 | 3 | 3 | 1 | 3 | |
| 0 | 0 | 0 | 0 | 0 | ||
C. jejuni=Campylobacter jejuni, C. coli=Campylobacter coli
Antibiotic sensitivity pattern of the obtained thermophilic Campylobacter isolates.
| Antibiotic | Total isolates | Number resistant | Number intermediate | Number sensitive | % of resistant isolates |
|---|---|---|---|---|---|
| AMP | 38 | 2 | 5 | 31 | 5.3 |
| GEN | 38 | 1 | 7 | 30 | 2.6 |
| ERY | 38 | 0 | 0 | 38 | 0.0 |
| LE | 38 | 0 | 9 | 29 | 0.0 |
| CIP | 38 | 0 | 14 | 24 | 0.0 |
| NA | 38 | 38 | 0 | 0 | 100.0 |
| CTR | 38 | 0 | 9 | 29 | 0.0 |
| COT | 38 | 0 | 0 | 38 | 0.0 |
AMP=Ampicillin, GEN=Gentamicin, ERY=Erythromycin, LE=Levofloxacin, CIP=Ciprofloxacin, NA=Nalidixic acid, CTR=Ceftriaxone, COT=Co-trimoxazole
Antibiotic sensitivity pattern among Campylobacter isolates.
| Antibiotics | Number of isolates | |||
|---|---|---|---|---|
| Resistant | Intermediaste | Sensitive | ||
| Ampicillin | 0 | 1 | 8 | |
| 2 | 4 | 23 | ||
| Gentamicin | 1 | 1 | 7 | |
| 0 | 6 | 23 | ||
| Erythromycin | 0 | 0 | 9 | |
| 0 | 0 | 29 | ||
| Levofloxacin | 0 | 1 | 8 | |
| 0 | 8 | 21 | ||
| Ciprofloxacin | 0 | 3 | 6 | |
| 0 | 11 | 18 | ||
| Nalidixic acid | 9 | 0 | 0 | |
| 29 | 0 | 0 | ||
| Ceftriaxone | 0 | 2 | 7 | |
| 0 | 7 | 22 | ||
| Co-trimoxazole | 0 | 0 | 9 | |
| 0 | 0 | 29 | ||
C. jejuni=Campylobacter jejuni, C. coli=Campylobacter coli